Ancora Advisors’s Beam Therapeutics BEAM Stock Holding History

Ancora Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72K	Hold	50	–	–	﹤0.01%	1801
2026 Q1	$1.19K	Hold	50	–	–	﹤0.01%	2215
2025 Q4	$1.39K	Hold	50	–	–	﹤0.01%	2199
2025 Q3	$1.21K	Hold	50	–	–	﹤0.01%	1749
2025 Q2	$850	Hold	50	–	–	﹤0.01%	1769
2025 Q1	$976	Hold	50	–	–	﹤0.01%	1594
2024 Q4	$1.24K	Hold	50	–	–	﹤0.01%	1613
2024 Q3	$1.23K	Hold	50	–	–	﹤0.01%	1589
2024 Q2	$1.17K	Hold	50	–	–	﹤0.01%	1639
2024 Q1	$1.65K	Hold	50	–	–	﹤0.01%	1575
2023 Q4	$1.36K	Hold	50	–	–	﹤0.01%	1518
2023 Q3	$1.2K	Hold	50	–	–	﹤0.01%	1548
2023 Q2	$1.6K	Hold	50	–	–	﹤0.01%	1511
2023 Q1	$1.53K	Hold	50	–	–	﹤0.01%	1565
2022 Q4	$2K	Hold	50	–	–	﹤0.01%	1575
2022 Q3	$2K	Hold	50	–	–	﹤0.01%	1772
2022 Q2	$2K	Hold	50	–	–	﹤0.01%	1928
2022 Q1	$3K	Buy	+50	New	+$3.28K	﹤0.01%	2061

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Ancora Advisors's BEAM Position: Q2 2026 in Review

Ancora Advisors held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 50 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

Ancora Advisors first reported a position in BEAM in Q1 2022 and has held it in 18 quarters since. The position peaked at $3K in Q1 2022. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Ancora Advisors held 50 shares of Beam Therapeutics worth $1.72K as of Q2 2026.
Ancora Advisors left its Beam Therapeutics share count unchanged in Q2 2026.
Beam Therapeutics made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1801 holding.
Ancora Advisors first reported a position in Beam Therapeutics in Q1 2022 and has held it in 18 quarters since.
Ancora Advisors's Beam Therapeutics position peaked at $3K in Q1 2022.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.